4.4 Article

A three-dimensional human skin model to evaluate the inhibition of Staphylococcus aureus by antimicrobial peptide-functionalized silver carbon nanotubes

Journal

JOURNAL OF BIOMATERIALS APPLICATIONS
Volume 33, Issue 7, Pages 924-934

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/0885328218814984

Keywords

Scaffolds; cells; skin; Staphylococcus aureus; nanotechnology; antimicrobial peptide; carbon nanotubes

Funding

  1. National Science Foundation-CREST [HRD-1241701]
  2. NSF-HBCU-UP [HRD-1135863]
  3. National Institutes of Health MBRS-RISE [1R25GM106995-01]

Ask authors/readers for more resources

Objective To investigate the toxicity and antibacterial application of antimicrobial peptide-functionalized silver-coated carbon nanotubes against Staphylococcus infection using a full thickness human three-dimensional skin model. Materials and methods The three-dimensional skin formation on the scaffolds was characterized by electron microscopy and investigation of several skin cell markers by real time-reverse transcriptase polymerase chain reaction. Functionalized silver-coated carbon nanotubes were prepared using carboxylated silver-coated carbon nanotubes with antimicrobial peptides such as TP359, TP226 and TP557. Following the characterization and toxicity evaluation, the antibacterial activity of functionalized silver-coated carbon nanotubes against Staphylococcus aureus was investigated using a bacterial enumeration assay and scanning electron microscopy. For this purpose, a scar on the human three-dimensional skin grown on Alvetex scaffold using keratinocytes and fibroblasts cells was created by taking precaution not to break the scaffold beneath, followed by incubation with 5 mu g/mL of functionalized silver-coated carbon nanotubes re-suspended in minimum essential medium for 2 h. Post 2-h incubation, 200 mu L of minimum essential medium containing 1x10(4) colony forming units of Staphylococcus aureus were incubated for 2 h. After incubation with bacteria, the colony forming unit/gram (cfu/g) of skin tissue were counted using the plate count assay and the samples were processed for scanning electron microscopy analysis. Results MTT assay revealed no toxicity of functionalized silver-coated carbon nanotubes to the skin cells such as keratinocytes and fibroblasts at 5 mu g/mL with 98% cell viability. The bacterial count increased from 10(4) to 10(8) cfu/g in the non-treated skin model, whereas skin treated with functionalized silver-coated carbon nanotubes showed only a small increase from 10(4) to 10(5) cfu/g (1000-fold viable cfu difference). Scanning electron microscopy analysis showed the presence of Staphylococcus aureus on the non-treated skin as opposed to the treated skin. Conclusion Thus, our results showed that functionalized silver-coated carbon nanotubes are not only non-toxic, but also help reduce the infection due to their antibacterial activity. These findings will aid in the development of novel antibacterial skin substitutes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Active Hexose-Correlated Compound Restores Gene Expression and Protein Secretion of Protective Cytokines of Immune Cells in a Murine Stress Model during Chlamydia muridarum Genital Infection

Tesfaye Belay, Rajnish Sahu, Elisha Martin, Kristin Brown, Courtney Rolen, Shomonique Hankins, Brianna Punturi, Maya Patterson, Chase Chambers, Brandon Kirby, Jonathan Butchar

Summary: The study showed that oral feeding of AHCC in stressed mice reduced shedding of C. muridarum, decreased plasma catecholamines, promoted immune cell activation and cytokine production, and enhanced clearance of C. muridarum infection in the murine stress model.

INFECTION AND IMMUNITY (2021)

Article Environmental Sciences

Interaction of Soil Microbes with Organoclays and their Impact on the Immobilization of Hg under Aerobic Conditions

Timothy E. Egbo, Alexander Johs, Rajnish Sahu, Yazeed Abdelmageed, Jeffrey Ogbudu, Boakai K. Robertson

Summary: The study evaluates the impact of Serratia marcescens and Burkholderia thailandensis on the immobilization of mercury by sorbents, finding that common soil bacteria do not significantly affect mercury sorption by sorbent amendments. This suggests that sorbent amendments are an effective strategy for remediating mercury contamination in natural ecosystems.

WATER AIR AND SOIL POLLUTION (2021)

Article Virology

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

Richard S. Bennett, Elena N. Postnikova, Janie Liang, Robin Gross, Steven Mazur, Saurabh Dixit, Gregory Kocher, Shuiqing Yu, Shalamar Georgia-Clark, Dawn Gerhardt, Yingyun Cai, Lindsay Marron, Vladimir V. Lukin, Michael R. Holbrook

Summary: As the SARS-CoV-2 pandemic escalated, the need for effective neutralizing antibody testing became evident for the development of plasma-based therapies. By modifying and optimizing an existing fluorescence reduction neutralization assay, a high-quality neutralization assay for SARS-CoV-2 was achieved, allowing for quantitative assessment of infected cells and proficient screening of samples.

VIRUSES-BASEL (2021)

Article Immunology

Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge

Rajnish Sahu, Saurabh Dixit, Richa Verma, Skyla A. Duncan, Lula Smith, Guillermo H. Giambartolomei, Shree R. Singh, Vida A. Dennis

Summary: The PLGA-rMOMP nanovaccine demonstrated protective efficacy in mice against genital Chlamydia challenges by enhancing immune responses and inducing specific Th1 cytokines, antibodies, and T-cell phenotypes. The vaccine also showed potential for developing a nano-based Chlamydia vaccine by triggering cellular and humoral immune effectors through extended-releasing PLGA encapsulation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Chemistry, Medicinal

Nanofiller-Enhanced Soft Non-Gelatin Alginate Capsules for Modified Drug Delivery

Sameer Joshi, Rajnish Sahu, Vida A. Dennis, Shree R. Singh

Summary: The research combines alginate and montmorillonite to produce a soft non-gelatin modified-release capsule, which was critically analyzed for appearance, functionality, and durability. These capsules offer unique advantages in terms of appearance, functionality, and durability.

PHARMACEUTICALS (2021)

Review Chemistry, Medicinal

Breast Cancer Transcriptional Regulatory Network Reprogramming by using the CRISPR/Cas9 System: An Oncogenetics Perspective

Desh Deepak Singh, Ravi Verma, Subhash K. Tripathi, Rajnish Sahu, Poonam Trivedi, Dharmendra Kumar Yadav

Summary: Breast cancer is the second most commonly diagnosed cancer in the world, with treatment options remaining a challenge and a need for a comprehensive understanding of the interplay between genes and the development of more effective treatments. The use of CRISPR/Cas9 technology to generate BC-specific transgenic cell lines and animal models has been successfully employed, with significant potential for early BC diagnostic tools and treatments.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)

Article Immunology

Plasmodium Preerythrocytic Vaccine Antigens Enhance Sterile Protection in Mice Induced by Circumsporozoite Protein

Shaji Daniel, Alexander Pichugin, Holly Torano, Jonathan P. Renn, Jennifer Kwan, Matthew Cowles, Solomon Conteh, Lynn E. Lambert, Nada Alani, Nicholas J. MacDonald, Weili Dai, Kendrick Highsmith, Charles Anderson, J. Patrick Gorres, Javonn Musgrove, Brandi Butler, Nouf Althubaiti, Saurabh Dixit, Stasya Zarling-Bejma, Urszula Krzych, Patrick E. Duffy

Summary: Preerythrocytic vaccines target parasites in the clinically silent sporozoite and liver stages to prevent malaria. Combining CSP with novel antigens like PEVAs may enhance sterile protective immunity.

INFECTION AND IMMUNITY (2021)

Article Multidisciplinary Sciences

Broadly neutralizing antibodies target the coronavirus fusion peptide

Cherrelle Dacon, Courtney Tucker, Linghang Peng, Chang-Chun D. Lee, Ting-Hui Lin, Meng Yuan, Yu Cong, Lingshu Wang, Lauren Purser, Jazmean K. Williams, Chul-Woo Pyo, Ivan Kosik, Zhe Hu, Ming Zhao, Divya Mohan, Andrew J. R. Cooper, Mary Peterson, Jeff Skinner, Saurabh Dixit, Erin Kollins, Louis Huzella, Donna Perry, Russell Byrum, Sanae Lembirik, David Drawbaugh, Brett Eaton, Yi Zhang, Eun Sung Yang, Man Chen, Kwanyee Leung, Rona S. Weinberg, Amarendra Pegu, Daniel E. Geraghty, Edgar Davidson, Iyadh Douagi, Susan Moir, Jonathan W. Yewdell, Connie Schmaljohn, Peter D. Crompton, Michael R. Holbrook, David Nemazee, John R. Mascola, Ian A. Wilson, Joshua Tan

Summary: This study identified six monoclonal antibodies that bind to spike proteins from all seven human-infecting coronaviruses. Two of these antibodies, COV44-62 and COV44-79, showed broad neutralizing activity against alpha- and betacoronaviruses, including the Omicron subvariants of SARS-CoV-2. The fusion peptide region in the spike protein was found to be a potential candidate epitope for next-generation coronavirus vaccine development.

SCIENCE (2022)

Review Microbiology

Pseudomonas aeruginosa reference strains PAO1 and PA14: A genomic, phenotypic, and therapeutic review

Amber Grace, Rajnish Sahu, Donald R. R. Owen, Vida A. A. Dennis

Summary: Pseudomonas aeruginosa is a common pathogen that has been identified as a multi-drug resistant strain. PAO1 and PA14, two laboratory strains, have contributed significantly to our understanding of the bacterium. However, there are discrepancies between their behaviors and therapeutic susceptibilities observed in human infections. This review aims to compare the two strains and propose methods to improve their clinical relevance.

FRONTIERS IN MICROBIOLOGY (2022)

Article Microbiology

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

Cherrelle Dacon, Linghang Peng, Ting-Hui Lin, Courtney Tucker, Chang-Chun D. Lee, Yu Cong, Lingshu Wang, Lauren Purser, Andrew J. R. Cooper, Jazmean K. Williams, Chul-Woo Pyo, Meng Yuan, Ivan Kosik, Zhe Hu, Ming Zhao, Divya Mohan, Mary Peterson, Jeff Skinner, Saurabh Dixit, Erin Kollins, Louis Huzella, Donna Perry, Russell Byrum, Sanae Lembirik, Michael Murphy, Yi Zhang, Eun Sung Yang, Man Chen, Kwanyee Leung, Rona S. Weinberg, Amarendra Pegu, Daniel E. Geraghty, Edgar Davidson, Benjamin J. Doranz, Iyadh Douagi, Susan Moir, Jonathan W. Yewdell, Connie Schmaljohn, Peter D. Crompton, John R. Mascola, Michael R. Holbrook, David Nemazee, Ian A. Wilson, Joshua Tan

Summary: In this study, 55 monoclonal antibodies were identified from COVID-19 convalescent donors that can bind diverse betacoronavirus spike proteins. Most antibodies targeted a non-neutralizing S2 epitope, but 11 antibodies targeting the stem helix showed neutralizing activity against different betacoronavirus lineages. These findings revealed a class of IGHV1-46/IGKV3-20 antibodies that can broadly neutralize betacoronaviruses by targeting the stem helix.

CELL HOST & MICROBE (2023)

Article Immunology

Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses

Duncan G. G. Ithinji, David W. W. Buchholz, Shahrzad Ezzatpour, I. Abrrey Monreal, Yu Cong, Julie Sahler, Amandip Singh Bangar, Brian Imbiakha, Viraj Upadhye, Janie Liang, Andrew Ma, Birgit Bradel-Tretheway, Benjamin Kaza, Yao Yu Yeo, Eun Jin Choi, Gunner P. P. Johnston, Louis Huzella, Erin Kollins, Saurabh Dixit, Shuiqing Yu, Elena Postnikova, Victoria Ortega, Avery August, Michael R. R. Holbrook, Hector C. C. Aguilar

Summary: This study demonstrates that replication-incompetent multivalent viral particle vaccines can provide protection against multiple deadly zoonotic viruses and have the potential for application in tropical regions.

NPJ VACCINES (2022)

Meeting Abstract Immunology

A recombinant Chlamydia muridarum MOMP encapsulated PLGA 85/15 nanovaccine induced antibodies elicited cross-recognition of serovar-D elementary bodies

Rajnish Sahu, Richa Verma, Homa Nath Sharma, Vanella Tadjuidje, Sameer Joshi, Othreniel A. Forte, Shree R. Singh, Vida A. Dennis

JOURNAL OF IMMUNOLOGY (2022)

No Data Available